MDCX insider filings

Medicus Pharma Ltd. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-17. Screen MDCX transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 14 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Bokhari Raza — Chief Executive Officer, Director, 10% owner2——3
Bonner Carolyn F. — President and CFO2——3
Brennan Edward J. — SVP, Medical Affairs2——3
Mehmud Faisal — Chief Medical Officer2——3
Smith Andrew Alasdair — Chief Operating Officer2——3
Ciaruffoli Robert J. — Director1——1
Kaiser Larry — Director1——1
MAHAFFY PATRICK J — Director1——1
May Sara R. — Director1——1

Recent insider filings — Medicus Pharma Ltd.

FiledFormInsiderReported transactionsSource
2026-11-174Smith Andrew Alasdair — Chief Operating OfficerGrant/award (A): 14,534 @ $1.72EDGAR
2026-11-174Mehmud Faisal — Chief Medical OfficerGrant/award (A): 14,534 @ $1.72EDGAR
2026-11-174May Sara R. — DirectorGrant/award (A): 5,813 @ $1.72EDGAR
2026-11-174MAHAFFY PATRICK J — DirectorGrant/award (A): 14,534 @ $1.72EDGAR
2026-11-174Kaiser Larry — DirectorGrant/award (A): 14,534 @ $1.72EDGAR
2026-11-174Ciaruffoli Robert J. — DirectorGrant/award (A): 72,674 @ $1.72EDGAR
2026-11-174Brennan Edward J. — SVP, Medical AffairsGrant/award (A): 14,534 @ $1.72EDGAR
2026-11-174Bokhari Raza — Chief Executive Officer, Director, 10% ownerGrant/award (A): 436,046 @ $1.72EDGAR
2026-11-174Bonner Carolyn F. — President and CFOGrant/award (A): 29,069 @ $1.72EDGAR
2026-09-084Bokhari Raza — Chief Executive Officer, DirectorGrant/award (A): 2,941,176 @ $0.17 · Grant/award (A): 500,000 (derivative) @ $0EDGAR
2026-09-084Bonner Carolyn F. — President and CFOGrant/award (A): 1,470,588 @ $0.17 · Grant/award (A): 250,000 (derivative) @ $0EDGAR
2026-09-084Brennan Edward J. — Chief Scientific OfficerGrant/award (A): 588,235 @ $0.17 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2026-09-084Mehmud Faisal — Chief Medical OfficerGrant/award (A): 1,470,588 @ $0.17 · Grant/award (A): 250,000 (derivative) @ $0EDGAR
2026-09-084Smith Andrew Alasdair — Chief Operating OfficerGrant/award (A): 735,294 @ $0.17 · Grant/award (A): 125,000 (derivative) @ $0EDGAR
2026-06-044Rodgers Cathy McMorris — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2026-06-044Raju Ajay — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2026-06-044Mehmud Faisal — Chief Medical OfficerGrant/award (A): 250,000 (derivative) @ $0EDGAR
2026-06-044May Sara R. — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2026-06-044Kaiser Larry — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2026-06-044Ciaruffoli Robert J. — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2026-06-044Brennan Edward J. — Chief Scientific OfficerGrant/award (A): 25,000 (derivative) @ $0EDGAR
2026-06-044Bonner Carolyn F. — President and CFOGrant/award (A): 250,000 (derivative) @ $0EDGAR
2026-06-044FISHMAN BARRY — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2026-06-044Bokhari Raza — Chief Executive Officer, DirectorGrant/award (A): 500,000 (derivative) @ $0EDGAR
2026-06-044Ashton William — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2026-06-044Smith Andrew Alasdair — Chief Operating OfficerGrant/award (A): 200,000 (derivative) @ $0EDGAR
2026-06-044MAHAFFY PATRICK J — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2026-04-014Rodgers Cathy McMorris — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2026-04-014Raju Ajay — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2026-04-014Mehmud Faisal — Chief Medical OfficerGrant/award (A): 125,000 (derivative) @ $0EDGAR
2026-04-014May Sara R. — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2026-04-014Kaiser Larry — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2026-04-014Ciaruffoli Robert J. — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2026-04-014Brennan Edward J. — Chief Scientific OfficerGrant/award (A): 25,000 (derivative) @ $0EDGAR
2026-04-014Bonner Carolyn F. — President and CFOGrant/award (A): 100,000 (derivative) @ $0EDGAR
2026-04-014FISHMAN BARRY — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2026-04-014Bokhari Raza — Chief Executive Officer, DirectorGrant/award (A): 325,000 (derivative) @ $0EDGAR
2026-04-014Ashton William — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2026-04-014Smith Andrew Alasdair — Chief Operating OfficerGrant/award (A): 50,000 (derivative) @ $0EDGAR
2026-04-014MAHAFFY PATRICK J — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2025-12-184May Sara R. — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2025-12-184Kaiser Larry — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2025-12-184Ciaruffoli Robert J. — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2025-12-184Brennan Edward J. — Chief Scientific OfficerGrant/award (A): 50,000 (derivative) @ $0EDGAR
2025-12-184Bonner Carolyn F. — President and CFOGrant/award (A): 75,000 (derivative) @ $0EDGAR
2025-12-184FISHMAN BARRY — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2025-12-184Bokhari Raza — Chief Executive Officer, DirectorGrant/award (A): 125,000 (derivative) @ $0EDGAR
2025-12-184Ashton William — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2025-12-184Smith Andrew Alasdair — Chief Operating OfficerGrant/award (A): 50,000 (derivative) @ $0EDGAR
2025-12-184MAHAFFY PATRICK J — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR

Recent 8-K events — Medicus Pharma Ltd.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-198-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-168-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
3.03 — Material Modification to Rights of Security Holders
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-048-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-238-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-168-K3.03 — Material Modification to Rights of Security Holders
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-078-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-148-K1.02 — Termination of a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-118-K3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-038-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-048-K5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=MDCX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs